Vertex Pharma stock gains as FDA clears trial (NASDAQ:VRTX)
Grandbrothers/iStock Editorial via Getty Images Vertex Pharmaceuticals (NASDAQ:VRTX) said Thursday the U.S. Food and Drug Administration (FDA) greenlighted a clinical ...
Grandbrothers/iStock Editorial via Getty Images Vertex Pharmaceuticals (NASDAQ:VRTX) said Thursday the U.S. Food and Drug Administration (FDA) greenlighted a clinical ...
Hailshadow Vertex Pharmaceuticals (NASDAQ:VRTX) said its gene therapy Casgevy has been approved by Saudi Arabian regulators for the treatment of ...
What is CryptoSlate Alpha?A web3 membership designed to empower you with cutting-edge insights and knowledge. Learn more ›Connected to AlphaWelcome! ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) UBS Biopharma Conference November 9, 2023 12:00 PM ET Company Participants Charlie Wagner - Executive Vice ...
Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The ...
iQoncept Buoyed by booming sales of its diabetes drugs, Eli Lilly (NYSE:LLY) was the best performing large pharma or biotech ...
Panuwat Dangsungnoen/iStock via Getty Images Seeking Contributors urged investors to buy AbbVie (NYSE:ABBV), Vertex Pharma (NASDAQ:VRTX), Genmab (GMAB) and a ...
Mongkol Onnuan Vertex (NASDAQ:VERX) is a relatively undervalued tax software player. While the company's revenue has grown in the teens, ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.